Metraipolis › archive › dc_eab7cd5ec33f

Biophysical and biochemical studies support PHD inhibitor development as a TPI deficiency therapy — Europe PMC PMID:41949155

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41949155
DOI
10.1242/jcs.264664
License (as archived)
solo-consultazione
Archived
2026-11-02T09:55:12.014Z
SHA-256 of the archived text
8b5cb07177322d89c9647b5b2af20cc024043db613099fcd29506f6fb1bee7ac
Stable URL of this page
https://metraipolis.com/documento/dc_eab7cd5ec33f

How to cite

Biophysical and biochemical studies support PHD inhibitor development as a TPI deficiency therapy — Europe PMC PMID:41949155 — Europe PMC (en), https://europepmc.org/article/MED/41949155 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eab7cd5ec33f (Metraipolis archive dc_eab7cd5ec33f, sha256 8b5cb07177322d89c9647b5b2af20cc024043db613099fcd29506f6fb1bee7ac)
BibTeX
@misc{dceab7cd5ec33f,
  title = {Biophysical and biochemical studies support PHD inhibitor development as a TPI deficiency therapy — Europe PMC PMID:41949155},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41949155},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eab7cd5ec33f; sha256 8b5cb07177322d89c9647b5b2af20cc024043db613099fcd29506f6fb1bee7ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41949155. Agents can read the archived copy with the MCP tool read_document.